Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Present And Forecasted Size Of The Glioma Treatment Market?

The market size for treating gliomas has significantly expanded in the recent past. The market, which stood at $5.06 billion in 2024, is expected to rise to $5.37 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.1%. Factors such as an increased prevalence of glioma cases, progress in molecular comprehension, evolvement of conventional therapies, advances in research and clinical trials, and enhancements in imaging and diagnostic methodologies contributed to this uptick during the historic period.

In the upcoming years, it is anticipated that the glioma treatment market will experience substantial growth. The market is projected to increase to a value of $6.94 billion by 2029, with an annual growth rate of 6.6%. Factors that will contribute to this growth during the forecast period include the integration of personalized therapies, advancements in immunotherapy, biomarker discovery, the utilization of targeted therapies, the development of new therapeutic platforms, and cooperative research initiatives. Upcoming trends within this period will be the use of agents that can penetrate the blood-brain barrier, employing liquid biopsies for monitoring purposes, an emphasis on improving patient’s life quality and offering supportive care, as well as genetic and molecular subtyping, and promoting patient advocacy and involvement.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10689&type=smp

What Drivers Are Accelerating Expansion Of The Glioma Treatment Market?

The expansion of the glioma treatment market is anticipated to be spurred by an increasing demand for personalized medicine. This particular approach to healthcare customizes treatments based on individual idiosyncrasies, encompassing genetics, environment, and lifestyle habits, thereby promoting an improvement in treatment outcomes. Progress in genomics, patient involvement, and enhanced treatment efficacy are some of the key factors bolstering the call for personalized medicine. The discovery of biomarkers associated with gliomas facilitate the prediction of the efficacy and results of treatments, fostering the creation of bespoke treatment plans suited to each patient’s distinct features. For example, the Personalized Medicine Coalition, a non-profit organization in the U.S., reported in February 2024 that the FDA gave approval to 16 new personalized treatments for patients with rare illnesses in 2023, a significant increase from the six in the previous year. Thus, the intensifying demand for personalized medicine is fueling the growth of the glioma treatment market.

What Are The Primary Segmentation Parameters In The Glioma Treatment Market?

The glioma treatmentmarket covered in this report is segmented –

1) By Type: Low-Grade; High-Grade

2) By Disease: Glioblastoma Multiforme; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma; Other Diseases

3) By Route Of Administration: Oral; Parenteral; Other Routes

4) By Treatment: Surgery; Radiation Therapy; Chemotherapy; Targeted Drug Therapy; Other Treatments

5) By End-User: Hospitals; Specialty Clinics; Other End Users

Subsegments:

1) By Low-Grade: Astrocytoma; Oligodendroglioma; Mixed Glioma

2) By High-Grade: Glioblastoma Multiforme; Anaplastic Astrocytoma; Anaplastic Oligodendroglioma

How Are Industry Trends Steering The Expansion Of The Glioma Treatment Market?

A central trend growing its influence in the glioma treatment market is the focus on product innovation. Major players in this market are developing novel and state-of-the-art products to uphold their standing within the industry. For instance, Servier Pharmaceuticals, headquartered in France, acquired FDA approval in June 2024 for their VORANIGO (vorasidenib) tablets, which have gained significance as the premier targeted therapy designed for Grade 2 IDH-mutant glioma. Vorasidenib functions by targeting isocitrate dehydrogenase (IDH) 1 and 2 mutations, commonly present in gliomas. These mutations generate a tumor-growth-promoting metabolite, 2-hydroxyglutarate (2-HG). Vorasidenib, by inhibiting these enzymes, is able to reduce the 2-HG levels, potentially inhibiting tumor progression.

Which Players Are Shaping The Competitive Landscape Of The Glioma Treatment Market?

Major companies operating in the glioma treatment market include Merck & Co Inc., Amgen Inc., F Hoffmann-La Roche AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Arbor Pharmaceuticals LLC, Amneal Pharmaceuticals Inc., Karyopharm Therapeutics Inc., Bristol-Myers Squibb Co., Rigel Pharmaceuticals Inc., Sumitomo Dainippon Pharma Oncology Inc., Emcure Pharmaceuticals Ltd., Novartis AG, AstraZeneca plc, Eli Lilly and Company, Sanofi S.A., Johnson & Johnson, AbbVie Inc., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Bayer AG, Gilead Sciences Inc., Ipsen Pharma, Eisai Co. Ltd., Genentech Inc., Iovance Biotherapeutics Inc., Agios Pharmaceuticals Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/glioma-treatment-global-market-report

What Are The Emerging Regional Trends Driving The Glioma Treatment Market?

North America was the largest region in the glioma treatment market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global glioma treatment market report during the forecast period. The regions covered in the glioma treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=10689&type=smp

Browse Through More Reports Similar to the Global Glioma Treatment Market 2025, By The Business Research Company

Gastrointestinal Bleeding Treatment Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

Gastrointestinal Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report

Medical Equipment Maintenance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-equipment-maintenance-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model